|
Volumn 13, Issue 6, 2001, Pages 599-603
|
The tripeptide feG reduces endotoxin-provoked perturbation of intestinal motility and inflammation
|
Author keywords
Endotoxaemia; Immunomodulation; Intestinal motility; Leucocytes; Salivary glands
|
Indexed keywords
CD18 ANTIGEN;
LIPOPOLYSACCHARIDE;
PEPTIDE DERIVATIVE;
PEPTIDE FRAGMENT;
PHENYLALANYLGLUTAMYLGLYCINE;
THREONYLASPARAGINYLISOLEUCYLPHENYLALANYLGLUTAMYLGLYCYLGLYCINE;
TRIPEPTIDE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
ENDOTOXEMIA;
ENTERITIS;
INFLAMMATORY CELL;
INTESTINE MOTILITY;
LEUKOCYTE;
MALE;
MESENTERY;
MIGRATING MYOELECTRIC COMPLEX;
MUSCLE TISSUE;
NONHUMAN;
PERITONEAL CAVITY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RAT;
SUBMANDIBULAR GLAND;
ANIMALS;
ENDOTOXINS;
ENTERITIS;
GASTROINTESTINAL MOTILITY;
HISTOCYTOCHEMISTRY;
INJECTIONS, INTRAPERITONEAL;
INTESTINE, SMALL;
JEJUNUM;
LIPOPOLYSACCHARIDES;
MACROPHAGE ACTIVATION;
MACROPHAGES;
MACROPHAGES, PERITONEAL;
MALE;
OLIGOPEPTIDES;
PERITONEAL LAVAGE;
RATS;
RATS, SPRAGUE-DAWLEY;
|
EID: 0035685957
PISSN: 13501925
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2982.2001.00294.x Document Type: Article |
Times cited : (17)
|
References (22)
|